Ditchcarbon
  • Contact
  1. Organizations
  2. Mikart, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

Mikart, LLC Sustainability Profile

Company website

Mikart, LLC, a prominent player in the pharmaceutical and biotechnology sectors, is headquartered in the United States. Founded in 1984, the company has established itself as a leader in contract manufacturing and development services, primarily serving the needs of the life sciences industry. With a strong operational presence across North America, Mikart is renowned for its innovative solutions in drug formulation and packaging. The company offers a diverse range of core services, including custom formulation development, analytical testing, and regulatory support, all tailored to meet the unique demands of its clients. Mikart's commitment to quality and compliance has earned it a solid reputation, positioning it as a trusted partner for pharmaceutical companies seeking reliable manufacturing solutions. Notable achievements include successful collaborations with major industry players, underscoring its significant market presence and expertise.

DitchCarbon Score

How does Mikart, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Mikart, LLC's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Mikart, LLC's reported carbon emissions

Mikart, LLC, headquartered in the US, has not disclosed specific carbon emissions data for the years 2023 and 2025. However, it has indicated a commitment to reducing greenhouse gas emissions, with a reported reduction of approximately 0.4% in 2023 related to unspecified greenhouse gas emissions. For 2025, the company noted a reduction of about 0.06% in emissions associated with electricity and water use. Currently, Mikart, LLC does not have any established reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of detailed emissions data, including Scope 1, 2, and 3 emissions, suggests that the company may still be in the early stages of formalising its climate strategy. As of now, Mikart, LLC's climate commitments appear to be in line with industry trends, focusing on gradual improvements in sustainability practices without specific numerical targets or comprehensive emissions disclosures.

How Carbon Intensive is Mikart, LLC's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mikart, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Mikart, LLC's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mikart, LLC is in US, which has a low grid carbon intensity relative to other regions.

Mikart, LLC's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Mikart, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Mikart, LLC's Emissions with Industry Peers

Cardinal Health

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Catalent

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Mckesson

CA
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy